Repositioning Drugs for New Indications or Markets
Summary: The pharma industry is constantly looking for ways to shorten timelines, improve efficiencies, and increase patient impact. One way companies can achieve these goals and reach new patient populations is by repositioning drugs, allowing them to leverage research and development which has been completed for medicines already on the market or in the clinic. The process of repositioning drugs for new indications or new markets can pose unique considerations. In this interview, Catalent expert Judith Jones discusses the challenges associated with advancing a repositioned drug and how to overcome them to achieve strategic success.